Metastatic differentiated thyroid carcinoma: clinical management and outcome of disease in patients with initial and late distant metastases
OBJECTIVEOur objective was to analyze the clinical management and the outcome of disease in differentiated thyroid carcinoma with initial and late distant metastases (M1). PATIENTS AND METHODSRadioiodine (I) therapy was applied in 77 differentiated thyroid carcinoma patients with M1 (31 patients wit...
Saved in:
Published in: | Nuclear medicine communications Vol. 30; no. 7; pp. 558 - 564 |
---|---|
Main Authors: | , , , , |
Format: | Journal Article |
Language: | English |
Published: |
England
Lippincott Williams & Wilkins, Inc
01-07-2009
|
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Abstract | OBJECTIVEOur objective was to analyze the clinical management and the outcome of disease in differentiated thyroid carcinoma with initial and late distant metastases (M1).
PATIENTS AND METHODSRadioiodine (I) therapy was applied in 77 differentiated thyroid carcinoma patients with M1 (31 patients with M1-initial and 46 patients with M1-late). The median follow-up of patients was 72.7 months. Probability of disease-specific survival (DSS) was analyzed by the Kaplan–Meier method and the log rank test, while the significance of differences between groups was calculated by the t-test of proportions.
RESULTSFollicular carcinomas were more frequent in patients with M1-late (P<0.05). During the follow-up, 58% of the patients died39% of cases had disease related deaths, while 42% had complete remission of disease. Stable disease and progressive disease were significantly influenced by age only (P = 0.0122), while I uptake, histological type, and sex had no influence (P = 0.1235; P = 0.340; P = 0.8540, respectively). Remission of disease (complete and partial) was not significantly influenced by age, sex, histological type, and I accumulation (P = 0.0644; P = 0.8452; P = 0.6308; P = 0.7675, respectively). DSS in patients with M1-initial and M1-late at 5 years was 71 and 50%, respectively and 62 and 41% at 10 years, respectively, without significant difference (P = 0.2582). Disease related deaths appeared more frequent in patients at 45 years of age or older, significantly caused by distant metastases (P<0.001).
CONCLUSIONDistant metastases occur late more often in patients with follicular carcinoma while M1-initial is detected more often in patients with papillary carcinoma. DSS was not significantly different among patients with M1-intial and M1-late. The risk of death from M1 increased after the age of 45 years. |
---|---|
AbstractList | OBJECTIVEOur objective was to analyze the clinical management and the outcome of disease in differentiated thyroid carcinoma with initial and late distant metastases (M1).
PATIENTS AND METHODSRadioiodine (I) therapy was applied in 77 differentiated thyroid carcinoma patients with M1 (31 patients with M1-initial and 46 patients with M1-late). The median follow-up of patients was 72.7 months. Probability of disease-specific survival (DSS) was analyzed by the Kaplan–Meier method and the log rank test, while the significance of differences between groups was calculated by the t-test of proportions.
RESULTSFollicular carcinomas were more frequent in patients with M1-late (P<0.05). During the follow-up, 58% of the patients died39% of cases had disease related deaths, while 42% had complete remission of disease. Stable disease and progressive disease were significantly influenced by age only (P = 0.0122), while I uptake, histological type, and sex had no influence (P = 0.1235; P = 0.340; P = 0.8540, respectively). Remission of disease (complete and partial) was not significantly influenced by age, sex, histological type, and I accumulation (P = 0.0644; P = 0.8452; P = 0.6308; P = 0.7675, respectively). DSS in patients with M1-initial and M1-late at 5 years was 71 and 50%, respectively and 62 and 41% at 10 years, respectively, without significant difference (P = 0.2582). Disease related deaths appeared more frequent in patients at 45 years of age or older, significantly caused by distant metastases (P<0.001).
CONCLUSIONDistant metastases occur late more often in patients with follicular carcinoma while M1-initial is detected more often in patients with papillary carcinoma. DSS was not significantly different among patients with M1-intial and M1-late. The risk of death from M1 increased after the age of 45 years. OBJECTIVEOur objective was to analyze the clinical management and the outcome of disease in differentiated thyroid carcinoma with initial and late distant metastases (M1).PATIENTS AND METHODSRadioiodine (131I) therapy was applied in 77 differentiated thyroid carcinoma patients with M1 (31 patients with M1-initial and 46 patients with M1-late). The median follow-up of patients was 72.7 months. Probability of disease-specific survival (DSS) was analyzed by the Kaplan-Meier method and the log rank test, while the significance of differences between groups was calculated by the t-test of proportions.RESULTSFollicular carcinomas were more frequent in patients with M1-late (P<0.05). During the follow-up, 58% of the patients died: 39% of cases had disease related deaths, while 42% had complete remission of disease. Stable disease and progressive disease were significantly influenced by age only (P = 0.0122), while 131I uptake, histological type, and sex had no influence (P = 0.1235; P = 0.340; P = 0.8540, respectively). Remission of disease (complete and partial) was not significantly influenced by age, sex, histological type, and 131I accumulation (P = 0.0644; P = 0.8452; P = 0.6308; P = 0.7675, respectively). DSS in patients with M1-initial and M1-late at 5 years was 71 and 50%, respectively and 62 and 41% at 10 years, respectively, without significant difference (P = 0.2582). Disease related deaths appeared more frequent in patients at 45 years of age or older, significantly caused by distant metastases (P<0.001).CONCLUSIONDistant metastases occur late more often in patients with follicular carcinoma while M1-initial is detected more often in patients with papillary carcinoma. DSS was not significantly different among patients with M1-initial and M1-late. The risk of death from M1 increased after the age of 45 years. Our objective was to analyze the clinical management and the outcome of disease in differentiated thyroid carcinoma with initial and late distant metastases (M1). Radioiodine (131I) therapy was applied in 77 differentiated thyroid carcinoma patients with M1 (31 patients with M1-initial and 46 patients with M1-late). The median follow-up of patients was 72.7 months. Probability of disease-specific survival (DSS) was analyzed by the Kaplan-Meier method and the log rank test, while the significance of differences between groups was calculated by the t-test of proportions. Follicular carcinomas were more frequent in patients with M1-late (P<0.05). During the follow-up, 58% of the patients died: 39% of cases had disease related deaths, while 42% had complete remission of disease. Stable disease and progressive disease were significantly influenced by age only (P = 0.0122), while 131I uptake, histological type, and sex had no influence (P = 0.1235; P = 0.340; P = 0.8540, respectively). Remission of disease (complete and partial) was not significantly influenced by age, sex, histological type, and 131I accumulation (P = 0.0644; P = 0.8452; P = 0.6308; P = 0.7675, respectively). DSS in patients with M1-initial and M1-late at 5 years was 71 and 50%, respectively and 62 and 41% at 10 years, respectively, without significant difference (P = 0.2582). Disease related deaths appeared more frequent in patients at 45 years of age or older, significantly caused by distant metastases (P<0.001). Distant metastases occur late more often in patients with follicular carcinoma while M1-initial is detected more often in patients with papillary carcinoma. DSS was not significantly different among patients with M1-initial and M1-late. The risk of death from M1 increased after the age of 45 years. |
Author | Malesevic, Milica D Mihailovic, Jasna M Stefanovic, Ljubomir J Erak, Marko D Tesanovic, Dusanka D |
AuthorAffiliation | Departments of Nuclear Medicine and Radiotherapy, Oncology Institute of Vojvodina, Institutski put, Sremska Kamenica, Serbia |
AuthorAffiliation_xml | – name: Departments of Nuclear Medicine and Radiotherapy, Oncology Institute of Vojvodina, Institutski put, Sremska Kamenica, Serbia |
Author_xml | – sequence: 1 givenname: Jasna surname: Mihailovic middlename: M fullname: Mihailovic, Jasna M organization: Departments of Nuclear Medicine and Radiotherapy, Oncology Institute of Vojvodina, Institutski put, Sremska Kamenica, Serbia – sequence: 2 givenname: Ljubomir surname: Stefanovic middlename: J fullname: Stefanovic, Ljubomir J – sequence: 3 givenname: Milica surname: Malesevic middlename: D fullname: Malesevic, Milica D – sequence: 4 givenname: Marko surname: Erak middlename: D fullname: Erak, Marko D – sequence: 5 givenname: Dusanka surname: Tesanovic middlename: D fullname: Tesanovic, Dusanka D |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/19436230$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kU1vEzEQhi1URNPCP0DIJ25b7B1nveGGKj4qNXCB82rWniUGrx1sr6L-B340DomE1AMnS6NnnrHe94pdhBiIsZdS3Eix0W-2n7c3YhQSCNoeWmNaHJ-wlVQamnXX9hdsJaSCBjroLtlVzj-EED10-hm7lBsFXQtixX5vqWAuWJzh1k0TJQrFYSHLy-4hRWe5wWRciDO-5ca74Ax6PmPA7zRXlmOwPC7FxJl4nKokE2biLvB9tVYi84MruzpwVez_8r4eOJIFq2A-_SBTfs6eTugzvTi_1-zbh_dfbz81918-3t2-u28MrNXYaA2dWCuppabeEmpQPVmr4BhDr62hngB7i0oh4AYnUkpBq0nULEaScM1en7z7FH8tlMswu2zIewwUlzx01bhRAiqoTqBJMedE07BPbsb0MEgxHFsYagvD4xbq2quzfxlnsv-WzrFXoD8Bh-gLpfzTLwdKw47Ql93_3X8AQPGcOQ |
CitedBy_id | crossref_primary_10_1016_j_raem_2017_05_001 crossref_primary_10_1097_RLU_0000000000005138 crossref_primary_10_1007_s00268_013_2006_9 crossref_primary_10_1089_thy_2016_0582 crossref_primary_10_1007_s12020_018_1713_2 crossref_primary_10_1016_j_bcp_2011_08_021 crossref_primary_10_1308_rcsann_2016_0300 crossref_primary_10_4103_ijem_ijem_455_21 crossref_primary_10_1089_thy_2011_0535 crossref_primary_10_1634_theoncologist_2009_0190 crossref_primary_10_1007_s00259_016_3485_3 crossref_primary_10_1007_s00405_017_4532_9 crossref_primary_10_1007_s12020_019_01991_0 crossref_primary_10_1007_s12149_011_0559_y crossref_primary_10_1007_s00268_013_2213_4 |
Cites_doi | 10.1046/j.1365-2265.2002.01482.x 10.1016/j.surg.2007.06.011 10.1111/j.1365-2265.2005.02358.x 10.1002/1097-0142(19840215)53:4<982::AID-CNCR2820530427>3.0.CO;2-E 10.1067/msy.2000.109728 10.1016/0046-8177(90)90228-W 10.1053/jpsu.2000.6935 10.1002/1097-0142(19881001)62:7<1381::AID-CNCR2820620724>3.0.CO;2-R 10.1677/ERC-07-0229 10.1111/j.1365-2265.2005.02304.x 10.1089/thy.1999.9.1227 10.1016/S1072-7515(03)00332-6 10.1210/jcem-63-4-960 10.1210/jc.2005-2838 10.1055/s-0037-1620881 10.1002/cncr.22956 10.1210/jcem-56-6-1131 10.1097/00000478-200208000-00005 10.1259/0007-1285-57-676-323 10.1016/S0002-9610(97)00158-X 10.1210/jcem-67-3-501 |
ContentType | Journal Article |
Copyright | 2009 Lippincott Williams & Wilkins, Inc. |
Copyright_xml | – notice: 2009 Lippincott Williams & Wilkins, Inc. |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 |
DOI | 10.1097/MNM.0b013e32832cc2ab |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: ECM name: MEDLINE url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1473-5628 |
EndPage | 564 |
ExternalDocumentID | 10_1097_MNM_0b013e32832cc2ab 19436230 10.1097/MNM.0b013e32832cc2ab |
Genre | Journal Article |
GroupedDBID | - .Z2 0R 123 4Q1 4Q2 4Q3 53G 5VS 71W 8L- 8WZ A6W AAPBV AARTV AAYEP ABBUW ABXVJ ABZAD ACDDN ACEWG ACGFS ACWDW ACWRI ACXNZ ADFPA ADNKB AE3 AENEX AFUWQ AHULI AHVBC AJIOK AJNYG ALMA_UNASSIGNED_HOLDINGS AMJPA ASCII AWKKM BQLVK C45 CAG COF CS3 DU5 DUNZO E.X EBS EJD EX3 F2K F2L F5P FL- H0 H0~ HZ IN IN~ JF9 JG8 JK3 JK8 K8S KD2 KMI L-C N9A N~M O9- OAG OAH OCUKA ODA OHASI OL1 OLG OLV OLW OLZ OPUJH ORVUJ OUVQU OVD OVDNE OWW OWY OXXIT P-K P2P R58 RIG RLZ RSW S4R S4S V2I WOQ WOW X3V X3W Z2 ZA5 ZGI --- .-D 0R~ AAAAV AAHPQ AAIQE AASCR ABASU ABDIG ABJNI ABVCZ ACGFO ACILI ACXJB ADGGA ADHPY AE6 AEETU AFDTB AGINI AHQNM AHRYX AINUH AJNWD AJZMW ALMTX AMKUR AMNEI AOHHW BS7 CGR CUY CVF DIWNM ECM EEVPB EIF FCALG GNXGY GQDEL HLJTE HZ~ IKREB IPNFZ NPM OWU OWV OWX OWZ T8P TEORI TSPGW VVN W3M XXN XYM ZFV ZZMQN AAYXX CITATION 7X8 |
ID | FETCH-LOGICAL-c354b-77360541717e8dea7348edd43832c87dce8e3a8da44a3a9afe444327e0363be13 |
ISSN | 0143-3636 |
IngestDate | Thu Aug 15 23:16:37 EDT 2024 Fri Aug 23 02:11:33 EDT 2024 Sat Sep 28 07:46:26 EDT 2024 Thu Aug 13 19:53:28 EDT 2020 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 7 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c354b-77360541717e8dea7348edd43832c87dce8e3a8da44a3a9afe444327e0363be13 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 19436230 |
PQID | 67349403 |
PQPubID | 23479 |
PageCount | 7 |
ParticipantIDs | proquest_miscellaneous_67349403 crossref_primary_10_1097_MNM_0b013e32832cc2ab pubmed_primary_19436230 wolterskluwer_health_10_1097_MNM_0b013e32832cc2ab |
ProviderPackageCode | L-C C45 AARTV ADFPA ASCII OLG ODA ABZAD ABBUW JK3 ADNKB JK8 H0~ OLV 8L- JG8 OLW OLZ F2K F2L OHASI AHVBC AJNYG FL- KMI K8S AJIOK OPUJH V2I S4R S4S 4Q1 DUNZO OAG 4Q2 OVDNE 4Q3 AMJPA OAH OVD 71W AHULI ACEWG .Z2 AWKKM OUVQU ORVUJ X3V X3W ACDDN ACWRI E.X OWW OCUKA OWY ACXNZ OL1 ABXVJ IN~ KD2 OXXIT ACWDW JF9 |
PublicationCentury | 2000 |
PublicationDate | 2009-July 2009-Jul 2009-07-00 20090701 |
PublicationDateYYYYMMDD | 2009-07-01 |
PublicationDate_xml | – month: 07 year: 2009 text: 2009-July |
PublicationDecade | 2000 |
PublicationPlace | England |
PublicationPlace_xml | – name: England |
PublicationTitle | Nuclear medicine communications |
PublicationTitleAlternate | Nucl Med Commun |
PublicationYear | 2009 |
Publisher | Lippincott Williams & Wilkins, Inc |
Publisher_xml | – name: Lippincott Williams & Wilkins, Inc |
References | Decaussin (R26-13-20210212) 2002; 26 Ruegemer (R6-13-20210212) 1988; 67 Durante (R18-13-20210212) 2006; 91 Dietlein (R20-13-20210212) 2005 Massin (R23-13-20210212) 1984; 53 Sampson (R1-13-20210212) 2007; 110 Shaha (R2-13-20210212) 1997; 174 Schlumberger (R7-13-20210212) 1986; 63 Schlumberger (R22-13-20210212) 1996; 37 Sugitani (R16-13-20210212) 2008; 143 Zetting (R27-13-20210212) 2002; 56 Smith (R29-13-20210212) 1988; 62 La Quaglia (R10-13-20210212) 2000; 35 Mizukami (R28-13-20210212) 1990; 21 Muresan (R3-13-20210212) 2008; 15 Stefanovic (R17-13-20210212) 2001; 6 Lin (R19-13-20210212) 1999; 9 Nemec (R24-13-20210212) 1979; 18 Brink (R9-13-20210212) 2001; 128 Haq (R11-13-20210212) 2005; 63 Samaan (R5-13-20210212) 1983; 56 Shoup (R4-13-20210212) 2003; 197 Sobin (R13-13-20210212) 2002 Brown (R8-13-20210212) 1984; 57 Mihailovic (R15-13-20210212) 2007; 22 Brierley (R14-13-20210212) 2005; 63 Pomorski (R21-13-20210212) 1999; 46 Dinneen (R25-13-20210212) 1995; 80 |
References_xml | – volume: 56 start-page: 377 year: 2002 ident: R27-13-20210212 article-title: Long-term follow-up of patients with bone metastases from differentiated thyroid carcinoma-surgery or conventional therapy? publication-title: Clin Endocrinol (Oxf) doi: 10.1046/j.1365-2265.2002.01482.x contributor: fullname: Zetting – volume: 46 start-page: 309 year: 1999 ident: R21-13-20210212 article-title: Metastasis as the first sign of thyroid cancer publication-title: Neoplasma contributor: fullname: Pomorski – volume: 143 start-page: 35 year: 2008 ident: R16-13-20210212 article-title: Papillary thyroid carcinoma with distant metastases: survival predictors and the importance of local control publication-title: Surgery doi: 10.1016/j.surg.2007.06.011 contributor: fullname: Sugitani – volume: 63 start-page: 418 year: 2005 ident: R14-13-20210212 article-title: Prognostic factors and the effect of treatment with radioactive iodine and external radiation on patients with differentiated thyroid cancer seen at a single institution over 40 years publication-title: Clin Endocrinol (Oxf) doi: 10.1111/j.1365-2265.2005.02358.x contributor: fullname: Brierley – volume: 22 start-page: 250 year: 2007 ident: R15-13-20210212 article-title: Differentiated thyroid carcinoma with distant metastases: probability of survival and its predicting factors publication-title: Cancer Biother Radipharm contributor: fullname: Mihailovic – volume: 53 start-page: 982 year: 1984 ident: R23-13-20210212 article-title: Pulmonary metastases in differentiated thyroid carcinoma. Study of 58 cases with implications for the primary tumor treatment publication-title: Cancer doi: 10.1002/1097-0142(19840215)53:4<982::AID-CNCR2820530427>3.0.CO;2-E contributor: fullname: Massin – volume: 128 start-page: 881 year: 2001 ident: R9-13-20210212 article-title: Papillary thyroid cancer with pulmonary metastases in children: long-term prognosis publication-title: Surgery doi: 10.1067/msy.2000.109728 contributor: fullname: Brink – volume: 21 start-page: 283 year: 1990 ident: R28-13-20210212 article-title: Distant metastases in differentiated thyroid carcinomas: a clinical and pathologic study publication-title: Human Pathology doi: 10.1016/0046-8177(90)90228-W contributor: fullname: Mizukami – volume: 35 start-page: 955 year: 2000 ident: R10-13-20210212 article-title: Differentiated thyroid cancer: clinical characteristics, treatment, and outcome in patients with distant metastases. A report from the surgical discipline committee of the children's cancer group publication-title: J Pediatr Surg doi: 10.1053/jpsu.2000.6935 contributor: fullname: La Quaglia – volume: 62 start-page: 1381 year: 1988 ident: R29-13-20210212 article-title: Mortality from papillary thyroid carcinoma. A case-control study of 56 lethal cases publication-title: Cancer doi: 10.1002/1097-0142(19881001)62:7<1381::AID-CNCR2820620724>3.0.CO;2-R contributor: fullname: Smith – volume: 15 start-page: 37 year: 2008 ident: R3-13-20210212 article-title: Bone metastases from differentiated thyroid carcinoma publication-title: Endocr Relat Cancer doi: 10.1677/ERC-07-0229 contributor: fullname: Muresan – volume: 63 start-page: 87 year: 2005 ident: R11-13-20210212 article-title: Differentiated thyroid carcinoma with distant metastases at presentation: prognostic factors and outcome publication-title: Clin Endocrinol doi: 10.1111/j.1365-2265.2005.02304.x contributor: fullname: Haq – volume: 9 start-page: 1227 year: 1999 ident: R19-13-20210212 article-title: Factors related to the survival of papillary and follicular thyroid carcinoma patients with distant metastases publication-title: Thyroid doi: 10.1089/thy.1999.9.1227 contributor: fullname: Lin – volume: 80 start-page: 2041 year: 1995 ident: R25-13-20210212 article-title: Distant metastases in papillary thyroid carcinoma: 100 cases observed at one institution during 5 decades publication-title: J Clin Endocrinol Metab contributor: fullname: Dinneen – volume: 197 start-page: 191 year: 2003 ident: R4-13-20210212 article-title: Prognostic Indicators of outcomes in patients with distant metastases from differentiated thyroid carcinoma publication-title: J Am Coll Surg doi: 10.1016/S1072-7515(03)00332-6 contributor: fullname: Shoup – volume: 6 start-page: 263 year: 2001 ident: R17-13-20210212 article-title: Treatment outcome in patients with differentiated thyroid carcinoma and distant metastases publication-title: J BUON contributor: fullname: Stefanovic – volume: 63 start-page: 960 year: 1986 ident: R7-13-20210212 article-title: Long-term results of treatment of 283 patients with lung and bone metastases from differentiated thyroid carcinoma publication-title: J Clin Endocrinol Metab doi: 10.1210/jcem-63-4-960 contributor: fullname: Schlumberger – volume: 91 start-page: 2892 year: 2006 ident: R18-13-20210212 article-title: Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2005-2838 contributor: fullname: Durante – year: 2002 ident: R13-13-20210212 article-title: TNM classification of malignant tumours. 6th ed contributor: fullname: Sobin – volume: 18 start-page: 86 year: 1979 ident: R24-13-20210212 article-title: Radioiodine treatment of pulmonary metastases of differentiated thyroid cancer. Results and prognostic factors publication-title: Nuklearmedizin doi: 10.1055/s-0037-1620881 contributor: fullname: Nemec – start-page: 95 year: 2005 ident: R20-13-20210212 article-title: Thyroid cancer. 2nd ed contributor: fullname: Dietlein – volume: 110 start-page: 1451 year: 2007 ident: R1-13-20210212 article-title: 2007 Clinical management and outcome of papillary and follicular (differentiated) thyroid cancer presenting with distant metasasis at diagnosis publication-title: Cancer doi: 10.1002/cncr.22956 contributor: fullname: Sampson – volume: 56 start-page: 1131 year: 1983 ident: R5-13-20210212 article-title: Impact of therapy for differentiated carcinoma of the thyroid: analysis of 706 cases publication-title: J Clin Endocrinol Metab doi: 10.1210/jcem-56-6-1131 contributor: fullname: Samaan – volume: 26 start-page: 1007 year: 2002 ident: R26-13-20210212 article-title: Thyroid carcinomas with distant metastases: a review of 111 cases with emphasis on the prognostic significance of an insular component publication-title: Am J Surg Pathol doi: 10.1097/00000478-200208000-00005 contributor: fullname: Decaussin – volume: 57 start-page: 323 year: 1984 ident: R8-13-20210212 article-title: Radioiodine treatment of metastatic thyroid carcinoma: the Royal Marsden Hospital experience publication-title: Br J Radiol doi: 10.1259/0007-1285-57-676-323 contributor: fullname: Brown – volume: 174 start-page: 474 year: 1997 ident: R2-13-20210212 article-title: Differentiated thyroid cancer presenting initially with distant metasrtasis publication-title: Am J Surg doi: 10.1016/S0002-9610(97)00158-X contributor: fullname: Shaha – volume: 67 start-page: 501 year: 1988 ident: R6-13-20210212 article-title: Distant metasatsis in differentiated thyroid carcinoma: a multivariate analysis of prognostic variables publication-title: J Clin Endocrinol Metab doi: 10.1210/jcem-67-3-501 contributor: fullname: Ruegemer – volume: 37 start-page: 598 year: 1996 ident: R22-13-20210212 article-title: Radioactive iodine treatment and external radiotherapy for lung and bone metastases from thyroid carcinoma publication-title: J Nucl Med contributor: fullname: Schlumberger |
SSID | ssj0008367 |
Score | 1.9877352 |
Snippet | OBJECTIVEOur objective was to analyze the clinical management and the outcome of disease in differentiated thyroid carcinoma with initial and late distant... Our objective was to analyze the clinical management and the outcome of disease in differentiated thyroid carcinoma with initial and late distant metastases... |
SourceID | proquest crossref pubmed wolterskluwer |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 558 |
SubjectTerms | Age Factors Female Humans Iodine Radioisotopes - therapeutic use Male Middle Aged Neoplasm Metastasis Retrospective Studies Survival Rate Thyroid Neoplasms - pathology Thyroid Neoplasms - radiotherapy Thyroid Neoplasms - therapy Time Factors Treatment Outcome |
Title | Metastatic differentiated thyroid carcinoma: clinical management and outcome of disease in patients with initial and late distant metastases |
URI | https://www.ncbi.nlm.nih.gov/pubmed/19436230 https://search.proquest.com/docview/67349403 |
Volume | 30 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1ba9swFBZpC2NjjN2bXfWwt2EWW3Jk7610KS3E2cNS6JuRZYW5beySxOxP7EfvHEuyknXs8rAXExQhG3-fzznSuRHyTidgdicg_RbRWAVcxyxIkzgKQrbQXIXFSHQZcqdfxOwi-TThk8HAdWb0Y_8VaRgDrDFz9h_Q7heFAfgNmMMVUIfrX-Ge6Y3ELKFK9c1P4CNGuxIgWTVVicWoVVU3y64rT58ZuezjYDp_QtNu4Om6AwXrw3nvq7DalLgKA49srYFruAXOxKbE2JYan2Ft4xMvXYqvwh4VvTsfw9l9ckpv22fVV1ldNyDBTBTvupbbTY_1Qtbuz-llWzTLauV9WxnoO9T1yqQE4Imkj2merOSVy09q7LA78Ej74FjQV0ZIc8ECsNuSbSluvTuGrWJLJMemNLzV7rGpmX5LcZiCxNkscyfD2MJJqUgWXlG64IDZ5_zkfDrN55OL-R45iEDEgYQ9ODo-m571VkDCxsKlaqbiw69W3jWFbu1v7pH73xoMmVhfdRkTW3bP_CF5YDcs9Mgw7REZ6PoxuZNZDJ-Q755wdJdw1BKO9oT7SB3dqKcbBfpQSzfaLKilG61q6uhGkW7U0q2bj3Sjlm7U0-0pOT-ZzI9PA9viI1As5gXs7Rjsp3koQqGTUkustaTLEuvnRioRpdKJZjIpJeeSyVSCAOGcRUJj_EGhQ_aM7NdNrQ8JleNoFI-KMowUg0m8KJQOUz7iukiVFNGQBO5t5zemkkvuIjAAnfxndIbkrYMkB5GLfjRZ66ZdYygkh4XZkDw3SPn1Ug4GIRsNSbgDXW6Smn97vxd_vN9Lctd_D6_I_mbV6tdkb122byz7fgDqqMIE |
link.rule.ids | 315,782,786,27933,27934 |
linkProvider | Ovid |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Metastatic+differentiated+thyroid+carcinoma%3A+clinical+management+and+outcome+of+disease+in+patients+with+initial+and+late+distant+metastases&rft.jtitle=Nuclear+medicine+communications&rft.au=Mihailovic%2C+Jasna+M&rft.au=Stefanovic%2C+Ljubomir+J&rft.au=Malesevic%2C+Milica+D&rft.au=Erak%2C+Marko+D&rft.date=2009-07-01&rft.eissn=1473-5628&rft.volume=30&rft.issue=7&rft.spage=558&rft.epage=564&rft_id=info:doi/10.1097%2FMNM.0b013e32832cc2ab&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0143-3636&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0143-3636&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0143-3636&client=summon |